Suppression of T cells by mesenchymal and cardiac progenitor cells is partly mediated via extracellular vesicles
Adverse remodeling after myocardial infarction (MI) is strongly influenced by T cells. Stem cell therapy after MI, using mesenchymal stem cells (MSC) or cardiomyocyte progenitor cells (CMPC), improved cardiac function, despite low cell retention and limited differentiation. As MSC secrete many facto...
Main Authors: | F. van den Akker, K.R. Vrijsen, J.C. Deddens, J.W. Buikema, M. Mokry, L.W. van Laake, P.A. Doevendans, J.P.G. Sluijter |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-06-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844017339609 |
Similar Items
-
Targeting chronic cardiac remodeling with cardiac progenitor cells in a murine model of ischemia/reperfusion injury.
by: Janine C Deddens, et al.
Published: (2017-01-01) -
Anti-fibrotic Effects of Cardiac Progenitor Cells in a 3D-Model of Human Cardiac Fibrosis
by: Tom C. L. Bracco Gartner, et al.
Published: (2019-04-01) -
Cardiac-Derived Extracellular Matrix Enhances Cardiogenic Properties of Human Cardiac Progenitor Cells
by: Roberto Gaetani, et al.
Published: (2016-09-01) -
Extracellular vesicles from endothelial progenitor cells promote thyroid follicle formation
by: Jonathan Degosserie, et al.
Published: (2018-12-01) -
Neonatal Cardiovascular-Progenitor-Cell-Derived Extracellular Vesicles Activate YAP1 in Adult Cardiac Progenitor Cells
by: Camberos, V., et al.
Published: (2023)